The chemical compound sulforaphane found in broccoli sprouts can be linked to improved blood sugar levels in prediabetes, a ...

Scientists mapped fat tissue differences in obese individuals, uncovering cell changes linked to metabolic disease risk and ...

Austin Chiang, MD, MPH: One innovation that's happening in my specialty of gastroenterology is artificial intelligence. Ben ...

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (NYSE: LLY) announced ...

A new study has confirmed that weight loss or bariatric surgery is safe and very effective, and, for a large percentage of ...

Two emails sent days apart are raising new questions about why more wasn’t done to prevent the death of a 15-year-old boy ...

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a ...